MMedication Read More New Biosimilar Guidelines to ease Bioequivalence Study Norms: DCGI, ETPharmaApril 14, 2026 New Delhi: The upcoming guidance for the development and manufacturing of biosimilar drugs in India will reduce the…
MMedication Read More 90 FDC drug samples, including Paracetamol and multivitamins, found unapproved; regulator asks states to take actionMarch 25, 2026 ANI | Updated: Mar 23, 2026 10:31 IST By Shalini BhardwajNew Delhi [India], March 23 (ANI): The Drug…
MMedication Read More 90 FDC drug samples, including Paracetamol, found unapproved; regulator asks states to take actionMarch 24, 2026 NEW DELHI: The Drug Controller General of India (DCGI) has launched a nationwide crackdown on unapproved Fixed Dose…